JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
Hematopoietic stem cell transplantation for hemoglobinopathies in adults
By Thalita Cristina de Mello Costa, Adriana Seber, George Maurício Navarro Barros and 7 others.
Abstract
Background
Hemoglobinopathies are the most prevalent monogenic disorders worldwide, and allogeneic hematopoietic stem cell transplantation (HSCT) remains the only established curative treatment.
Objective
To provide an updated version of the Brazilian consensus published by the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation, incorporating recent advances in allogeneic HSCT for adults with hemoglobinopathies.
